Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale)
- PMID: 19001561
- DOI: 10.1093/ndt/gfn566
Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale)
Abstract
Background: Little is known about antihypertensive management and control of blood pressure (BP) and proteinuria in patients with chronic kidney disease (CKD). Data from a large observational study (AVENIR), carried out in Lorraine (France), were used to analyse antihypertensive treatment and control of BP and proteinuria in patients with advanced CKD, under nephrologist care or not.
Methods: All adults with CKD, beginning dialysis in 2005 and 2006, were included and categorized into patients 'under nephrologist care' and 'not under nephrologist care' at the time when treatment, BP and proteinuria results were considered. All data were collected retrospectively from medical records. Demographic and clinical data were from initiation of dialysis. BP, biological and therapeutic data were results obtained at 2.7 months before dialysis for patients under nephrologist care, and results obtained at the first nephrology consultation for those not under such care (2.7 +/- 3.7 months before dialysis).
Results: On 566 included patients, the 291 under nephrologist care received more antihypertensive agents (3.1 +/- 1.5 versus 2.2 +/- 1.6) than the 275 not under such care and each antihypertensive class was more often prescribed for these patients, particularly the renin-angiotensin-aldosteron system inhibitors (60.5% versus 36.7%). Nevertheless, BP did not differ between both groups, and proteinuria control was achieved in more patients not under nephrologist care, revealing a likely bias of indication. Whatever the type of care, BP < 130/80 mmHg was achieved in only one quarter of all patients and proteinuria < 0.5 g/day in only 15% of them.
Conclusion: Understanding the reasons for such a poor level of hypertension and proteinuria control in CKD patients needs to be explored in further investigations.
Similar articles
-
Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study.J Eval Clin Pract. 2009 Feb;15(1):121-8. doi: 10.1111/j.1365-2753.2008.00965.x. J Eval Clin Pract. 2009. PMID: 19239592
-
Blood pressure control and comorbidity in a nephrology clinic.J Nephrol. 2004 Nov-Dec;17(6):808-12. J Nephrol. 2004. PMID: 15593055
-
Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.Am J Kidney Dis. 2006 Jan;47(1):78-87. doi: 10.1053/j.ajkd.2005.09.015. Am J Kidney Dis. 2006. PMID: 16377388
-
The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.Am J Hypertens. 2005 Apr;18(4 Pt 2):100S-105S. doi: 10.1016/j.amjhyper.2004.11.017. Am J Hypertens. 2005. PMID: 15837552 Review.
-
Out-of-office blood pressure monitoring in chronic kidney disease.Blood Press Monit. 2009 Feb;14(1):2-11. doi: 10.1097/MBP.0b013e3283262f58. Blood Press Monit. 2009. PMID: 19194283 Review.
Cited by
-
Course of chronic kidney disease in French patients.Clin Kidney J. 2017 Feb;10(1):74-78. doi: 10.1093/ckj/sfw092. Epub 2016 Sep 23. Clin Kidney J. 2017. PMID: 28638607 Free PMC article.
-
Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study.BMC Nephrol. 2011 Mar 15;12:12. doi: 10.1186/1471-2369-12-12. BMC Nephrol. 2011. PMID: 21406096 Free PMC article.
-
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.PLoS One. 2013 Dec 31;8(12):e84848. doi: 10.1371/journal.pone.0084848. eCollection 2013. PLoS One. 2013. PMID: 24391978 Free PMC article. Clinical Trial.
-
Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter?Drugs. 2014 Feb;74(2):159-68. doi: 10.1007/s40265-013-0175-3. Drugs. 2014. PMID: 24442793
-
Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study.Int Urol Nephrol. 2013 Oct;45(5):1345-53. doi: 10.1007/s11255-012-0332-8. Epub 2012 Dec 7. Int Urol Nephrol. 2013. PMID: 23225078
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical